These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34559414)

  • 21. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
    Rono CK; Darkwa J; Meyer D; Makhubela BCE
    Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic and Medicinal Perspective of 1,2,4-Triazole as Anticancer Agents.
    Rathod B; Kumar K
    Chem Biodivers; 2022 Nov; 19(11):e202200679. PubMed ID: 36226542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review.
    Kaur R; Dwivedi AR; Kumar B; Kumar V
    Anticancer Agents Med Chem; 2016; 16(4):465-89. PubMed ID: 26286663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances (2015-2016) in anticancer hybrids.
    Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
    Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents.
    Genc M; Karagoz Genc Z; Tekin S; Sandal S; Sirajuddin M; Hadda Taibi B; Sekerci M
    Acta Chim Slov; 2016 Dec; 63(4):726-737. PubMed ID: 28004087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid-triazole conjugates: A brief overview of synthesis and their application as anticancer agents.
    Agarwal DS; Sakhuja R; Beteck RM; Legoabe LJ
    Steroids; 2023 Sep; 197():109258. PubMed ID: 37330161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents.
    Le-Nhat-Thuy G; Dinh TV; Pham-The H; Nguyen Quang H; Nguyen Thi N; Dang Thi TA; Hoang Thi P; Le Thi TA; Nguyen HT; Nguyen Thanh P; Le Duc T; Nguyen TV
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3741-3747. PubMed ID: 30337229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An insight on medicinal attributes of 1,2,4-triazoles.
    Aggarwal R; Sumran G
    Eur J Med Chem; 2020 Nov; 205():112652. PubMed ID: 32771798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
    Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
    Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,2,4-Triazole hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Ge X; Xu Z
    Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000223. PubMed ID: 32985011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.
    Matiadis D; Sagnou M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
    Khaybullin RN; Liang X; Cisneros K; Qi X
    Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
    Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
    Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current development of pyrazole-azole hybrids with anticancer potential.
    Zhang S; Ye Y; Zhang Q; Luo Y; Wang ZC; Wu YZ; Zhang XP; Yi C
    Future Med Chem; 2023 Aug; 15(16):1527-1548. PubMed ID: 37610862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triazole nucleoside derivatives bearing aryl functionalities on the nucleobases show antiviral and anticancer activity.
    Xia Y; Qu F; Peng L
    Mini Rev Med Chem; 2010 Aug; 10(9):806-21. PubMed ID: 20482498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triazoles: a valuable insight into recent developments and biological activities.
    Sahu JK; Ganguly S; Kaushik A
    Chin J Nat Med; 2013 Sep; 11(5):456-65. PubMed ID: 24359767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.